Issues March 5th & 12th, 201216 March 2012
BUBENDORF, Switzerland (March 16, 2012) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, was featured in two weekly issues of Chemical and Engineering News (C&EN) dated:
March 5th, 2012 - Ann M. Thayer, correspondent for C&EN interviewed Mark C. Griffiths, CEO CARBOGEN AMCIS on the annual custom chemical manufacturing trade convention in the US Informex. "Fine chemical and custom manufacturing executives have started the year with a sense of guarded optimism" stated Ann. M. Thayer and several companies are diversifying their offering via acquisitions. Mark C. Griffiths explained the strategy behind CARBOGEN AMCIS’ recent move into the fill & finish arena through the acquisition of the France-based site in Riom specialized in the development and manufacture of parenteral drugs for clinical trials. The article can be viewed on line (access to ACS members only): http://cen.acs.org/signin.html?resource=/content/cen/articles/90/i10/Companies-Race-Diversify
March 12th, 2012 - Rick Mullin correspondent for C&EN interviewed Dr. Thomas Schlatterer, Sales Manager CARBOGEN AMCIS for a C&EN cover story entitled, "Pharma Outsourcing - Today’s cash-strapped biotechnology firms need more assistance than ever from their manufacturing partners." by Michael McCoy, Ann M. Thayer, Rick Mullin. The story showcases three case studies of successful collaboration and winning partnerships between three innovators and three service providers. During the interview Thomas Schlatterer explained Rick Mullin how CARBOGEN AMCIS helped Probiodrug to develop a new a small-molecule therapy for Alzheimer’s disease. Probiodrug is a biopharmaceutical company based in Halle (Saale), Germany focused on the development of innovative oral drugs for the treatment of major age related diseases and outsourcing development and manufacturing services to CARBOGEN AMCIS since several years. The article can be viewed on line: http://cen.acs.org/articles/90/i11/Pharma-Outsourcing.html
CARBOGEN AMCIS AG (www.carbogen-amcis.com) is a leading service provider, offering a portfolio of drug-development and commercialization services to the pharmaceutical and biopharmaceutical industry at all stages of drug development. The integrated services provide innovative chemistry solutions to support timely and safe drug development allowing customers to make the best use of available resources. CARBOGEN AMCIS AG is owned by Dishman Pharmaceuticals and Chemicals Ltd., Ahmedabad, India.
Dishman Group (www.dishmangroup.com) is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and commercial API manufacturing services. Dishman Group improves its customers’ businesses by providing a range of development and manufacturing solutions at locations in Europe, China and India.
Probiodrug (www.probiodrug.de) is a biopharmaceutical company dedicated to the discovery and development of small molecule drugs against novel molecular targets for the treatment of neuronal- and inflammatory diseases. The Company has a dominant position in the area of glutaminyl cyclase inhibition. Glutaminyl cyclase, a novel enzyme target discovered and patented by Probiodrug, has a crucial role in the pathogenesis of Alzheimer’s disease (AD) as well as various peripheral inflammatory diseases.
Chemical & Engineering News (C&EN) (cen.acs.org/index.html) is a weekly magazine published by the American Chemical Society. C&EN editors and reporters based in Europe, the U.S., and Asia cover science and technology, business and industry, government and policy, education, and employment aspects of the chemistry field. C&EN Online offers Latest News, supplementary material to C&EN print articles, back issues of the magazine since 1998, and special features such as Reel Science, NanoFocus, RSS feeds, and blogs. Chemical & Engineering News has a global circulation of over 133,000 according to their website.
Informex (www.informex.com) is the annual custom chemical manufacturing trade convention in the US organized by the Synthetic Organic Chemical Manufacturers Association (SOCMA). Informex began as a table top exhibition over 28 years ago, and has grown into a four day chemical industry event featuring a tradeshow exhibition, conference, and several networking receptions. The must-attend event will feature nearly 500 exhibitors and around 4,000 attendees all focusing on the global chemical market.